High-expressed SFRP4, which correlates with a poor prognosis of gastric cancer, can activate the Wnt pathway to promote tumor progression and predict a poor survival of patients suffering from gastric cancer (Li et al., 2021). This evidence concerns the gene SFRP4 and gastric cancer.